OMass Therapeutics raised €273M in a Series C round in Oct 2026. The company is based in Oxford, UK. Investors in the round: Bain Capital Life Sciences, British Business Bank, Forbion and 10 others. Data as of 21 Oct 2026.
Confidence is the weaker of amount-FX and source evidence (the cascade rule). See methodology.
